Squarepoint
CGEM icon

Squarepoint’s Cullinan Oncology CGEM Stock Holding History

Squarepoint’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,820
Closed -$785K – 4360
2025
Q4 		$785K Sell
75,820
-14,498
-16% -$131K ﹤0.01% 2822
2025
Q3 		$536K Buy
90,318
+75,310
+502% +$552K ﹤0.01% 3180
2025
Q2 		$113K Buy
+15,008
New +$121K ﹤0.01% 4142
2025
Q1 		– Sell
-19,101
Closed -$233K – 4682
2024
Q4 		$233K Sell
19,101
-11,673
-38% -$168K ﹤0.01% 4355
2024
Q3 		$515K Buy
30,774
+20,105
+188% +$357K ﹤0.01% 3068
2024
Q2 		$186K Buy
+10,669
New +$227K ﹤0.01% 3678
2024
Q1 		– Sell
-20,067
Closed -$204K – 4120
2023
Q4 		$204K Buy
+20,067
New +$178K ﹤0.01% 3582
2023
Q2 		– Sell
-15,502
Closed -$159K – 3612
2023
Q1 		$159K Buy
+15,502
New +$171K ﹤0.01% 2871

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return